MAPT and Alzheimer disease: Animal studies have shown that the suppression of ROS and MDA levels in AD mice leads to increased expression of Ras, p-Raf, p-MEK, and p-ERK proteins, while enhancing SOD activity, consequently reducing Aβ and tau protein levels.